Talis Biomedical Corporation (TLIS) reports Q1 results
Tweet
Share
E-mailGet Alerts TLIS Hot Sheet
Join SI Premium – FREE
Talis Biomedical Corporation (NASDAQ: TLIS) reported Q1 results. Revenue for the quarter came in at $1.2 million versus the consensus estimate of $230 thousand.
For earnings history and earnings-related data on Talis Biomedical Corporation (TLIS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c
- The LGL Group (LGL) Misses Q2 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
